SI-BONE (SIBN) Earnings Analysis
SI-BONE (SIBN) next reports earnings on 2026-08-03, consensus EPS -0.15 USD. Last quarter (2026-05-11) it beat with EPS -0.1 USD vs -0.17 USD est (+41.2%). It has beaten estimates in 7/7 recent quarters (100%). Trailing P/E -43.08.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does SIBN next report earnings?
| Next earnings date | 2026-08-03 |
|---|---|
| Consensus EPS estimate | -0.15 USD |
| Revenue estimate | 0.06B |
SIBN earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.1 USD | -0.17 USD | +41.2% | Beat |
| 2026-02-23 | -0.04 USD | -0.13 USD | +69.2% | Beat |
| 2025-11-10 | -0.11 USD | -0.16 USD | +31.3% | Beat |
| 2025-08-04 | -0.14 USD | -0.19 USD | +26.3% | Beat |
| 2025-05-05 | -0.15 USD | -0.24 USD | +37.5% | Beat |
| 2025-02-24 | -0.11 USD | -0.14547 USD | +24.4% | Beat |
| 2024-08-05 | -0.22 USD | -0.26 USD | +15.4% | Beat |
Beat rate: 7/7 (100%) over reported quarters with consensus data.
SIBN valuation and analyst view
| Trailing P/E | -43.08 |
|---|---|
| Trailing EPS | -0.37989 USD |
| Price / book | 4.11 |
| Dividend yield | 0.00% |
| Market cap | 0.74B |
| Analyst consensus | Buy (9 buy / 0 hold / 0 sell) |
| Avg price target | 21 USD |
Related research pages
Frequently asked questions
When is SI-BONE (SIBN)'s next earnings date?
SI-BONE is next scheduled to report on 2026-08-03, with a consensus EPS estimate of -0.15 USD and revenue estimate of 0.06B.
Did SIBN beat earnings last quarter?
In its 2026-05-11 report, SIBN posted EPS of -0.1 USD versus a -0.17 USD estimate — a beat of 41.2%.
What is SIBN's earnings track record?
Over the last 7 reported quarters with consensus data, SIBN beat estimates 7 times (100%).
What is SIBN's current P/E ratio and EPS?
SIBN trades at a trailing P/E of -43.08 on trailing EPS of -0.37989288385559883 USD.
What do analysts rate SIBN?
Analyst consensus is "Buy" across 9 ratings (0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 21 USD.